3-D Matrix is a leading medical device company, which optimises MIT-founded, self-assembling peptide technology to continually innovate and serve healthcare professionals around the globe. One of its flagship products is the haemostatic hydrogel, PuraBond(1).
PuraBond utilises its unique ready-to-use, transparent properties to improve bleeding management and patient outcomes in ENT surgery across a range of procedures, including functional endoscopic sinus surgery (FESS), adult tonsillectomy, and rhinoplasty.
(1)PuraBond IFU-009 Rev2
Website: www.3dmatrix.com